Tetanus Immunisation in a Cohort of Adults Seen in an Accident and Emergency Unit of a Tertiary Health Facility in Nigeria
Nigerian Journal of Health Sciences · 02.11.2023 · 16 (2) · 96-99
DOI: 10.67853/0dj1xn58 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nigerian Journal of Health Sciences, online erschienen am 02.11.2023. Verfasst von Akinyoola AL und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Tetanus remains a major health problem in many developing countries including Nigeria. Most cases of tetanus in the developing countries are in the young people under 40 years. In view of the high mortality from tetanus, prevention remains the best form of treatment.
Objective
The objective was to determine the effectiveness of anti‑tetanus immunisation in a cohort of Nigerian adult population.
Methods
Patients with open injuries and controls without open injuries were investigated. Blood samples for IgG  Anti-Tetanus Antibody (ATAb) assessments were taken from patients and controls on admission before giving anti‑tetanus toxoid (ATT) and at 4 weeks later. Serum ATAb was quantitated using Tetanus Toxoid IgG ELISA Kit (Demeditec Diagnostics, Germany). ATAb results were expressed in International Units per millilitre (IU/mL). ATAb levels > 0.1 IU/mL were considered protective.
Results
A total of 159 patients and 90 controls were studied. The mean of ATAb patient was 1.13 (2.37) IU/mL, higher than the mean of 0.76 (1.4) IU/mL) in controls. In both the patients and controls, females had higher baseline ATAb levels; this was statistically significant in controls(P < 0.002). Seventy‑five (47.2%) patients and 47 (52.2%) controls did not have protective ATAb levels. Four weeks after immunisation, the rise in ATAb was, however, >8‑fold and the percentage of patients that required immunisation dropped from 47.2% to 10%. Although 11 (30%) patients had a history of ATT, their serum ATAb was not higher than those who did not have a history of ATT ‑ 1.02 (1.51) IU/mL and 1.19 (2.67) IU/mL, respectively.
Conclusion
There was a good response to ATT immunisation. Therefore, anti‑tetanus immunisation should be continued in hospitals.
Zitieren
APA
AL, A., L, S., OA, A., & CO, I. (2023). Tetanus Immunisation in a Cohort of Adults Seen in an Accident and Emergency Unit of a Tertiary Health Facility in Nigeria. Nigerian Journal of Health Sciences, 16(2), 96-99. https://doi.org/10.67853/0dj1xn58
Vancouver
AL A, L S, OA A, CO I. Tetanus Immunisation in a Cohort of Adults Seen in an Accident and Emergency Unit of a Tertiary Health Facility in Nigeria. Nigerian Journal of Health Sciences. 2023;16(2):96-99. doi:10.67853/0dj1xn58
BibTeX
@article{AL2023,
author = {AL, Akinyoola and L, Salawu and OA, Adeloye and CO, Idowu},
title = {Tetanus Immunisation in a Cohort of Adults Seen in an Accident and Emergency Unit of a Tertiary Health Facility in Nigeria},
journal = {Nigerian Journal of Health Sciences},
year = {2023},
volume = {16},
number = {2},
pages = {96--99},
doi = {10.67853/0dj1xn58}
}
EUVIMED